C. Dayen

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors

Alberto Vogrig, Marine Fouret, Bastien Joubert et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 185 citations · Full text

Major changes in lung cancer over the last ten years in France: The KBP-CPHG studies

Chrystèle Locher, D. Debieuvre, D. Coëtmeur et al. · Lung Cancer · 2013 · 108 citations

Major Changes, Medicine, Smoking Related Lung Disease +7

Randomized phase II–III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial

Jean-Louis Pujol, A. Lavolé, Élisabeth Quoix et al. · Annals of Oncology · 2015 · 95 citations · Full text

Ifct-0802 Trial, Medicine, Metronomic Therapy +7

Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

Alexis B. Cortot, Clarisse Audigier-Valette, Olivier Molinier et al. · European Journal of Cancer · 2020 · 68 citations

Medicine, Cancer Management, Clinical Trials +8

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

D. Debieuvre, Olivier Molinier, L. Falchero et al. · The Lancet Regional Health - Europe · 2022 · 68 citations · Full text